Speakers
Dr. Ing. Michel Eppink
TU Delft/Byondis
Professor and chair holder TU Delft/Senior Advisor
Professor and chair holder Department of Biotechnology at TU Delft and Senior Advisor Byondis BV Professor Michel Eppink is an experienced Director with a demonstrated history of working in the biopharmaceutical industry. He is a strong professional skilled in Research and Development (R&D), Protein Chemistry, Life Sciences, Downstream Processing, Biorefinery, Biochemistry and Formulations
More information about this lecture will follow soon
Byondis
Delivering Breakthrough Solutions in Oncology Treatment
Driven to improve patients’ lives, Byondis is an independent, fully integrated biopharmaceutical research and development company creating innovative targeted medicines for cancer. The company is developing new biological entities (NBEs) with a focus on antibody-drug conjugates. Byondis’ development portfolio leverages its expertise in linker-drug (LD) technology, antibody-drug conjugation and disease biology.
Byondis’ fully integrated drug development capabilities cover all stages from pre-clinical and clinical R&D, production of clinical batches of the selected product candidates and regulatory filings, which are all done in-house.
Partners of Single-Use Event Leiden 2026
Single-Use Event Leiden 2026
Registration website for Single-Use Event Leiden 2026Single-Use Event Leiden 2026marketing@aleapublishers.nl
Single-Use Event Leiden 2026marketing@aleapublishers.nlhttps://www.single-use.nu/170266
2026-09-15
2026-09-15
OfflineEventAttendanceMode
EventScheduled
Single-Use Event Leiden 2026Single-Use Event Leiden 20260.00EUROnlineOnly2019-01-01T00:00:00Z
To be announcedTo be announced
event registration made easy
aanmelder.nl is the software partner for events.
Click here to discover the software.